Quality and safety in manufacturing have been at the forefront of Tabuk Pharmaceuticals organizational mission since its establishment and continue to play a crucial role in delivering market-leading medications to patients across the MENA region. 💊 A dedicated Quality Check team works around the clock, conducting approximately 15,000 random sample tests a month with an average pass rate of 99%. Over the years, these stringent quality control protocols have earned us 19 internationally accredited certifications. #Tabuk #QualityControl #PharmaExcellence #MENAHealthcare #QCStandard
Tabuk Pharmaceuticals Manufacturing Company
تصنيع المستحضرات الصيدلانية
A leading Saudi pharmaceutical company, providing high-quality healthcare solutions across the Middle East and Africa.
نبذة عنا
Established in 1994, Tabuk Pharmaceuticals is a leading Saudi pharmaceutical company operating in 17 countries across the Middle East and Africa. With advanced manufacturing sites in Tabuk, Dammam, Sudan, and Algeria, Tabuk Pharmaceuticals manufactures and distributes a wide range of pharmaceutical products, addressing various therapeutic fields, including central nervous, cardiovascular, respiratory, musculoskeletal, gastrointestinal systems, and anti-infectives. With over 2,400 qualified employees, Tabuk Pharmaceuticals’ commitment to quality and innovation has enabled the company to establish itself as a key player in the region's pharmaceutical industry. If you're passionate about making a difference in the pharmaceutical industry and want to be a part of our team, visit our career page to explore and apply for our latest job openings! https://careers.tabukpharmaceuticals.com
- الموقع الإلكتروني
-
https://careers.tabukpharmaceuticals.com/
رابط خارجي لـ Tabuk Pharmaceuticals Manufacturing Company
- المجال المهني
- تصنيع المستحضرات الصيدلانية
- حجم الشركة
- ١٠٠١ - ٥٠٠٠ موظف
- المقر الرئيسي
- Riyadh
- النوع
- شركة يملكها عدد قليل من الأشخاص
- تم التأسيس
- 1994
- التخصصات
- In-licensing of innovative/patented/differentiated products، Out-licensing of a number of our products to several companies around the globe، Export of more than 150 brands of our finished products to all our markets MENA، Western Europe، و CIS
المواقع الجغرافية
-
رئيسي
احصل على اتجاهات السير
P.O.Box 28170
11437 Saudi Arabia
Riyadh، SA
-
احصل على اتجاهات السير
P.O.Box 17442
11195 JORDAN
Amman، JO
موظفين في Tabuk Pharmaceuticals Manufacturing Company
-
Hussein Merchant
Empowering businesses with my expertise & proficiency in S/4HANA SAP Controlling: Product Costing, Material Ledger Actual Costing, Multi-Valuations…
-
Mohamed Darwish
Operational Excellence | Lean Manufacturing | TPM | Kaizen | Trainer | Change Agent
-
Amit Sarkar
Head - Talent, Organizational Effectiveness & Learning | Leadership Development
-
Jabar Meman
Senior Quality Specialist at Tabuk Pharmaceuticals Manufacturing Company
التحديثات
-
At Tabuk Pharmaceuticals, sustainability is at the core of our manufacturing principles. We proudly highlighted this commitment in our agreements during CPHI Middle East 2024 in Riyadh. We are pleased to announce the signing of a Memorandum of Understanding (MOU) between Tabuk Pharmaceuticals Manufacturing Company and Schneider Electric. This collaboration marks a significant step forward in our sustainability efforts, focused on utilizing Schneider Electric's innovative Resource Advisor Platform. This state-of-the-art tool will enable Tabuk Pharmaceuticals to effectively track carbon emissions and energy usage across all its locations, enhancing our environmental stewardship. Our partnership underscores a collective commitment to achieving 2025 Neutral Carbon Emissions, as both organizations strive to lead in environmental sustainability. 🌱 Ismail Shehada Farrukh Shad
-
-
Congratulations to our beloved Saudi Arabia on the incredible achievement of securing the 2034 FIFA World Cup! We’re celebrating this proud moment across all Tabuk Pharmaceuticals locations, from our factories to our offices, and even at the #CPHI exhibition in Riyadh. Together, we’re proudly cheering for our amazing nation! #SaudiArabia #WorldCup2034 #TogetherWeGrow بصوت واحد وفي كل مواقعنا بالمملكة ومصانعنا وحتى ضمن معرض #CPHI بالرياض نحتفل باستضافة السعودية لكأس العالم. نهتف #أهلا_بالعالم بصوت واحد لبلدنا العظيم! قلوبنا تعج بالفرحة ونتمنى المزيد من التقدم والازدهار لوطننا المشرّف، أرض المجد والعلياء. #تبوك_الدوائية #الصناعات_الدوائية #أهلا_بالعالم #كاس_العالم_2034 #معًا_ننمو
-
We are pleased to announce that Tabuk Pharmaceuticals has entered into an exclusive licensing and supply agreement with ISU ISU ABXIS CO.,LTD, a leading biotechnology company, to bring Abcertin (imiglucerase), a treatment for Gaucher disease, to the Middle East and North Africa (MENA) region. This partnership formalized during CPHI Middle East 2024 in Riyadh, underscores our commitment to providing innovative therapies for rare diseases. By collaborating with ISU Abxis, we aim to enhance access to life-saving treatments for patients across the MENA region. #TabukPharmaceuticals #ISUAbxis #CPHIMiddleEast #MENAHealthcare
-
-
With a value of 100,000,000 SR, Tabuk Pharmaceutical Company signs a strategic partnership with Bio-Thera Solutions in the presence of the Minister of Health, Mr. Fahad AlJalajel and the Chief Executive Officer of the Food and Drug Authority, Dr. Hisham Aljadhey, and the accompanying delegation. This partnership aims to Manufacture and Commercialize Ustekinumab, a Stelara® Biosimilar to the Middle East and North Africa (MENA) region during CPHI Middle East - Riyadh. By collaborating with Bio-Thera Solutions, we aim to enhance access to life-saving treatments for patients across the MENA region. #TabukPharmaceuticals #BioThera #CPHIMiddleEast #MENAHealthcare
-
-
We are proud to announce a strategic partnership with Mabwell, a leading biotechnology company, to bring biosimilar products to the Middle East and North Africa (MENA) region. This partnership, formalized during CPHI Middle East 2024 in Riyadh, underscores our commitment to providing innovative therapies for rare diseases and reflects Tabuk Pharmaceuticals’ commitment to expanding access to high-quality, innovative treatments for patients across the region. #TabukPharmaceuticals #Mabwell #CPHIMiddleEast #MENAHealthcare
-
-
We had an outstanding time at the Saudi Arabia's biggest pharmaceutical gathering, CPHI Middle East! 🙌 Our team had the opportunity to meet with hundreds of attendees, discussing plans and reflecting on recent local and regional pharmaceutical developments. We also explored new opportunities to expand our local and regional business reach, and signed several promising new partnership agreements. 🎬Here’s a recap of some our favorite moments⤵ #Tabuk #CPHI2024 #PharmaInnovation #MiddleEastPharma #CPHIMiddleEast #PharmaceuticalIndustry
-
A historical moment for Saudi Arabia and its great people, as we are named the host for the 2034 FIFA World Cup! #Tabuk #FIFAWorldCup2034 #SaudiArabia #Vision2030 اعظم كأس عالم في التاريخ قادم 💚🇸🇦💚 المستحيل ليس سعودياً يوم يسطر في التاريخ و إنجاز عظيم يضاف لتاريخنا الحافل بالطموح والإنجازات. السعودية تستضيف #كأس_العالم_2034! #تبوك_الدوائية #رؤية_2030 #كأس_العالم
-
-
Today, our CEO, Mr. Ismail Shehada, delivered an inspiring speech at CPHI Middle East, spotlighting the transformative potential of Saudi Arabia's pharmaceutical sector. He emphasized the crucial role of this thriving space and reaffirmed our commitment as an industry leader to empowering local talent to drive global investment and innovation. #TabukPharmaceuticals #CPHI #SaudiVision2030
Chief Executive Officer at Tabuk Pharmaceuticals | Transforming pharmaceutical operations for one of the region's leading pharmaceutical manufacturers
Grateful for the opportunity to share insights at CPHI today! It was an honor to spotlight the transformative growth of Saudi Arabia's pharmaceutical sector, discuss the pivotal role of this dynamic industry, and highlight the importance of empowering local talent to attract global investments and drive innovation. At Tabuk Pharmaceuticals Manufacturing Company, we remain committed to leading this journey and contributing to #SaudiArabiavision_2030 for a thriving, globally connected healthcare ecosystem. A big thank you to everyone who attended and engaged in this important conversation! Let’s continue building a brighter future together. 💡 #TabukPharmaceuticals #CPHI #SaudiVision2030
-
-
We were honored by the visit of H.E. Mr. Fahad AlJalajel, the Minister of Health, and H.E. Dr. Hisham Aljadhey, the CEO of Saudi FDA, with the presence of the CEO of Astra Industrial Group Mr. Mohammad Alhaqbani and the CEO of Tabuk Pharmaceuticals Dr. Ismail Shehada, during the first day of Tabuk Pharmaceuticals participation in #CPHI Middle East. This reflects our commitment to contributing to the development and growth of the pharmaceutical sector in the Kingdom, supporting the goals of #SaudiVision2030 تشرفنا بزيارة معالي وزير الصحة أ/فهد الجلال، ومعالي الرئيس التنفيذي للهيئة العامة للغذاء والدواء د/هشام الجضعي لجناح شركة تبوك الدوائية، بحضور الرئيس التنفيذي لمجموعة استرا الصناعية أ/ محمد الحقباني والرئيس التنفيذي لشركة تبوك الدوائية د.اسماعيل شحادة، وذلك خلال اليوم الاول من مشاركة تبوك الدوائية في معرض #CPHI في الشرق الأوسط مما يؤكد التزامنا في#تبوك_الدوائية بالمساهمة في تطوير وتنمية قطاع الدواء في المملكة دعمًا لتحقيق مستهدفات #رؤية_السعودية_2030
-